Table 1.
Characteristics of study participants.
| Participants Vaccinated with | Total Number of Participants (n) | Age (Mean ± SD) | Sex (Male/Female) |
|---|---|---|---|
| BNT162b2 (PfVac) | 52 | 46.7 ± 12.9 | 21/31 |
| ChAdOx1-S (AzVac) | 45 | 40.1 ± 11.4 | 16/29 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.